Follicle-stimulating hormone

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Follicle Stimulating Hormone
Follicle stimulating hormone, beta polypeptide
Identifiers
Symbol FSHB
Entrez 2488
HUGO 3964
OMIM 136530
RefSeq NM_000510
UniProt P01225
Other data
Locus Chr. 11 p13

WikiDoc Resources for

Follicle-stimulating hormone

Articles

Most recent articles on Follicle-stimulating hormone

Most cited articles on Follicle-stimulating hormone

Review articles on Follicle-stimulating hormone

Articles on Follicle-stimulating hormone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Follicle-stimulating hormone

Images of Follicle-stimulating hormone

Photos of Follicle-stimulating hormone

Podcasts & MP3s on Follicle-stimulating hormone

Videos on Follicle-stimulating hormone

Evidence Based Medicine

Cochrane Collaboration on Follicle-stimulating hormone

Bandolier on Follicle-stimulating hormone

TRIP on Follicle-stimulating hormone

Clinical Trials

Ongoing Trials on Follicle-stimulating hormone at Clinical Trials.gov

Trial results on Follicle-stimulating hormone

Clinical Trials on Follicle-stimulating hormone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Follicle-stimulating hormone

NICE Guidance on Follicle-stimulating hormone

NHS PRODIGY Guidance

FDA on Follicle-stimulating hormone

CDC on Follicle-stimulating hormone

Books

Books on Follicle-stimulating hormone

News

Follicle-stimulating hormone in the news

Be alerted to news on Follicle-stimulating hormone

News trends on Follicle-stimulating hormone

Commentary

Blogs on Follicle-stimulating hormone

Definitions

Definitions of Follicle-stimulating hormone

Patient Resources / Community

Patient resources on Follicle-stimulating hormone

Discussion groups on Follicle-stimulating hormone

Patient Handouts on Follicle-stimulating hormone

Directions to Hospitals Treating Follicle-stimulating hormone

Risk calculators and risk factors for Follicle-stimulating hormone

Healthcare Provider Resources

Symptoms of Follicle-stimulating hormone

Causes & Risk Factors for Follicle-stimulating hormone

Diagnostic studies for Follicle-stimulating hormone

Treatment of Follicle-stimulating hormone

Continuing Medical Education (CME)

CME Programs on Follicle-stimulating hormone

International

Follicle-stimulating hormone en Espanol

Follicle-stimulating hormone en Francais

Business

Follicle-stimulating hormone in the Marketplace

Patents on Follicle-stimulating hormone

Experimental / Informatics

List of terms related to Follicle-stimulating hormone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Follicle stimulating hormone (FSH) is a hormone synthesised and secreted by gonadotropes in the anterior pituitary gland. FSH and LH act synergistically in reproduction:

Structure

FSH is a glycoprotein. Each monomeric unit is a protein molecule with a sugar attached to it; two of these make the full, functional protein. Its structure is similar to LH, TSH, and hCG. The protein dimer contains 2 polypeptide units, labelled alpha and beta subunits. The alpha subunits of LH, FSH, TSH, and hCG are identical, and contain 92 amino acids. The beta subunits vary. FSH has a beta subunit of 118 amino acids (FSHB) that confers its specific biologic action and is responsible for interaction with the FSH-receptor.The sugar part of the hormone is composed of fucose, galactose, mannose, galactosamine, glucosamine, and sialic acid, the latter being critical for its biologic half-life. The half-life of FSH is 3-4 hours.

Genes

The gene for the alpha subunit is located on chromosome 6p21.1-23. It is expressed in different cell types. The gene for the FSH beta subunit is located on chromosome 11p13 and is expressed in gonadotropes of the pituitary cells, controlled by GnRH, inhibited by inhibin, and enhanced by activin.


Activity

In both males and females, FSH stimulates the maturation of germ cells. In females, FSH initiates follicular growth, specifically affecting granulosa cells. With the concomitant rise in inhibin B FSH levels then decline in the late follicular phase. This seems to be critical in selecting only the most advanced follicle to proceed to ovulation. At the end of the luteal phase, there is a slight rise in FSH that seems to be of importance to start the next ovulatory cycle.

Like its partner, LH, FSH release at the pituitary gland is controlled by pulses of gonadotropin-releasing hormone (GnRH). Those pulses, in turn, are subject to the estrogen feed-back from the gonads.

Disease states

FSH levels are normally low during childhood and, in women, high after menopause.

High FSH levels

High levels of Follicle Stimulating Hormome are indicative of situations where the normal restricting feedback from the gonad is absent, leading to an unrestricted pituitary FSH production. While this is typical in the menopause, it is abnormal in the reproductive years. There it may be a sign of:

  1. Premature menopause
  2. Gonadal dysgenesis, Turner syndrome
  3. Castration
  4. Swyer syndrome
  5. Certain forms of CAH
  6. Testicular failure

Low FSH levels

Diminished secretion of FSH can result in failure of gonadal function (hypogonadism). This condition is typically manifest in males as failure in production of normal numbers of sperm. In females, cessation of reproductive cycles is commonly observed. Conditions with very low FSH secretions are:

  1. Kallmann syndrome
  2. Hypothalamic suppression
  3. Hypopituitarism
  4. Hyperprolactinemia
  5. Gonadotropin deficiency
  6. Gonadal suppression therapy
    1. GnRH antagonist
    2. GnRH agonist (downregulation)

Availability

FSH is available mixed with LH in the form of Pergonal, and other more purified forms of urinary gonadotropins as well as in a pure forms as recombinant FSH (Gonal F, Follistim). It is used commonly in infertility therapy to stimulate follicular development, notably in IVF therapy.

External links

cs:Folikuly stimulující hormon

da:Follikelstimulerende hormon de:Follikelstimulierendes Hormonit:Ormone follicolo-stimolante he:הורמון מגרה זקיק lt:Folikulinas mk:Фоликуло-стимулирачки хормон nl:Follikelstimulerend hormoonno:Follikkelstimulerende hormonsk:Folikulostimulačný hormón sv:Follikelstimulerande hormon


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools